Liraglutide for the treatment of type 2 diabetes. [electronic resource]
Producer: 20120705Description: 77-86 p. digitalISSN:- 2046-4924
- Clinical Trials, Phase III as Topic
- Cost-Benefit Analysis
- Diabetes Mellitus, Type 2 -- drug therapy
- Drug Therapy, Combination
- Glucagon-Like Peptide 1 -- administration & dosage
- Glycated Hemoglobin
- Humans
- Hypoglycemic Agents -- administration & dosage
- Liraglutide
- Meta-Analysis as Topic
- Metformin -- therapeutic use
- Multicenter Studies as Topic
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic
- Weight Loss
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.